Literature DB >> 19565181

Increased serum brain-derived neurotrophic factor protein upon hypoxia in healthy young men.

Christian Hubold1, Undine E Lang, Hartmut Gehring, Bernd Schultes, Ulrich Schweiger, Achim Peters, Rainer Hellweg, Kerstin M Oltmanns.   

Abstract

Exposing animals to brief hypoxic periods leads to neuroprotective ischemic tolerance termed preconditioning. This phenomenon is well documented in the brain, but the underlying mechanisms require further elucidation. As nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) are important mediators of maintaining homeostatic conditions in the adult nervous system in terms of physiological and pathophysiological processes, we hypothesized that hypoxic preconditioning might modulate serum neurotrophin concentrations. Hypoxia was induced for 30 min in 14 healthy young men resulting in a constant blood oxygen saturation of 75%. Hyperinsulinemic euglycemic clamps were performed and serum concentrations of BDNF and NGF were measured at baseline, directly after the intervention, and at the end of the session. Overall, serum BDNF concentrations decreased over time by maximally 35% (P = 0.001) while in contrast NGF concentrations remained unchanged. Acute hypoxia alleviated the decrease of BDNF resulting in higher BDNF concentrations as compared to normoxic control (P < 0.01). Our findings show that acute hypoxia results in significantly higher serum BDNF concentrations pointing to a potential role of BDNF in the underlying mechanism of hypoxic preconditioning. Based on its neuroprotective properties, BDNF may be of high clinical relevance for therapeutic options in ischemic neurovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19565181     DOI: 10.1007/s00702-009-0257-2

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  29 in total

1.  Researchers focus on improving treatments for acute ischemic stroke.

Authors:  Mike Mitka
Journal:  JAMA       Date:  2006-04-12       Impact factor: 56.272

2.  Hypoxic preconditioning induces neuroprotective stanniocalcin-1 in brain via IL-6 signaling.

Authors:  Johan A Westberg; Martina Serlachius; Petri Lankila; Milena Penkowa; Juan Hidalgo; Leif C Andersson
Journal:  Stroke       Date:  2007-02-01       Impact factor: 7.914

Review 3.  Hypoxia preconditioning in the brain.

Authors:  Ruiqiong Ran; Huichun Xu; Aigang Lu; Myriam Bernaudin; Frank R Sharp
Journal:  Dev Neurosci       Date:  2005 Mar-Aug       Impact factor: 2.984

4.  Neurotrophins and their receptors: roles in plasticity, neurodegeneration and neuroprotection.

Authors:  A Hennigan; R M O'Callaghan; A M Kelly
Journal:  Biochem Soc Trans       Date:  2007-04       Impact factor: 5.407

5.  Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia.

Authors:  W R Schäbitz; C Sommer; W Zoder; M Kiessling; M Schwaninger; S Schwab
Journal:  Stroke       Date:  2000-09       Impact factor: 7.914

6.  BDNF and NGF afford in vitro neuroprotection against ethanol combined with acute ischemia and chronic hypoglycemia.

Authors:  J J Mitchell; M Paiva; D W Walker; M B Heaton
Journal:  Dev Neurosci       Date:  1999       Impact factor: 2.984

7.  Brain derived neurotrophic factor is increased in cerebrospinal fluid of children suffering from asphyxia.

Authors:  L Korhonen; R Riikonen; H Nawa; D Lindholm
Journal:  Neurosci Lett       Date:  1998-01-16       Impact factor: 3.046

8.  Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice.

Authors:  T Nakagawa; A Tsuchida; Y Itakura; T Nonomura; M Ono; F Hirota; T Inoue; C Nakayama; M Taiji; H Noguchi
Journal:  Diabetes       Date:  2000-03       Impact factor: 9.461

9.  A BDNF autocrine loop in adult sensory neurons prevents cell death.

Authors:  A Acheson; J C Conover; J P Fandl; T M DeChiara; M Russell; A Thadani; S P Squinto; G D Yancopoulos; R M Lindsay
Journal:  Nature       Date:  1995-03-30       Impact factor: 49.962

10.  Effects of mild hypoxia (2200 m) on catecholamine and corticosterone secretion.

Authors:  P Groza; C Vlădescu; J Boerescu
Journal:  Physiologie       Date:  1975
View more
  8 in total

Review 1.  Unexpected benefits of intermittent hypoxia: enhanced respiratory and nonrespiratory motor function.

Authors:  E A Dale; F Ben Mabrouk; G S Mitchell
Journal:  Physiology (Bethesda)       Date:  2014-01

2.  Effects of obstructive sleep apnea on serum brain-derived neurotrophic factor protein, cortisol, and lipid levels.

Authors:  Busarakumtragul Panaree; Mekseepralard Chantana; Sukhumsirichart Wasana; Neruntarat Chairat
Journal:  Sleep Breath       Date:  2010-09-24       Impact factor: 2.816

3.  The influence of a mild thermal challenge and severe hypoxia on exercise performance and serum BDNF.

Authors:  Jeroen Van Cutsem; Nathalie Pattyn; Dirk Vissenaeken; Gino Dhondt; Kevin De Pauw; Cajsa Tonoli; Romain Meeusen; Bart Roelands
Journal:  Eur J Appl Physiol       Date:  2015-05-31       Impact factor: 3.078

4.  Enhanced BDNF signalling following chronic hypoxia potentiates catecholamine release from cultured rat adrenal chromaffin cells.

Authors:  Angela L Scott; Min Zhang; Colin A Nurse
Journal:  J Physiol       Date:  2015-08-01       Impact factor: 5.182

Review 5.  Association between brain-derived neurotrophic factor levels and obstructive sleep apnea: a systematic review and meta-analysis.

Authors:  Amirmohammad Khalaji; Amir Hossein Behnoush; Parnian Shobeiri; Behrad Saeedian; Antonio L Teixeira; Nima Rezaei
Journal:  Sleep Breath       Date:  2022-09-17       Impact factor: 2.655

Review 6.  Effect of Hypoxic Injury in Mood Disorder.

Authors:  Fenglian Zhao; Junling Yang; Ranji Cui
Journal:  Neural Plast       Date:  2017-06-22       Impact factor: 3.599

7.  Acute normobaric hypoxia does not affect the simultaneous exercise-induced increase in circulating BDNF and GDNF in young healthy men: A feasibility study.

Authors:  Zofia Piotrowicz; Małgorzata Chalimoniuk; Kamila Płoszczyca K; Miłosz Czuba; Józef Langfort
Journal:  PLoS One       Date:  2019-10-23       Impact factor: 3.240

Review 8.  The Role of Inflammation, Hypoxia, and Opioid Receptor Expression in Pain Modulation in Patients Suffering from Obstructive Sleep Apnea.

Authors:  Piotr Kaczmarski; Filip Franciszek Karuga; Bartosz Szmyd; Marcin Sochal; Piotr Białasiewicz; Dominik Strzelecki; Agata Gabryelska
Journal:  Int J Mol Sci       Date:  2022-08-13       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.